ELDEPRYL (SELEGILINE HYDROCHLORIDE) — FDA Approval NDA020647 (QUAGEN)
ELDEPRYL (SELEGILINE HYDROCHLORIDE) — FDA Approval NDA020647 (QUAGEN) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: ELDEPRYL; Active ingredients: SELEGILINE HYDROCHLORIDE; Application number: NDA020647.
| Brand name | ELDEPRYL |
|---|---|
| Active ingredients | SELEGILINE HYDROCHLORIDE |
| Application number | NDA020647 |
| Sponsor | QUAGEN |
| Dosage form | CAPSULE |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 19960515 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →